HuGE Literature Finder
Records 1-30
|
Are cytochrome P4502D6 and apolipoprotein E genotypes associated with long-term cognitive and functional changes in patients treated with donepezil?
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society 2020 Apr . Pamio Maria V, Trevisan Caterina, Pigozzo Sabrina, De Rui Marina, Devita Maria, Girardi Agostino, Manzato Enzo, Sergi Giuseppe, Coin Alessand |
|
Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer's Dementia Are Frequently Below the Recommended Levels.
Frontiers in pharmacology 2020 11 691. Ortner Marion, Stange Marion, Schneider Heike, Schroeder Charlotte, Buerger Katharina, Müller Claudia, Dorn Bianca, Goldhardt Oliver, Diehl-Schmid Janine, Förstl Hans, Steimer Werner, Grimmer Ti |
|
Effect of genetic polymorphisms on Alzheimer's disease treatment outcomes: an update.
Clinical interventions in aging 2019 14 631-642. Sumirtanurdin Riyadi, Thalib Amirah Y, Cantona Kelvin, Abdulah Riz |
|
Clinical Response to Donepezil in Mild and Moderate Dementia: Relationship to Drug Plasma Concentration and CYP2D6 and APOE Genetic Polymorphisms.
Journal of Alzheimer's disease : JAD 2017 55 (2): 539-549. Miranda Luís F J R, Gomes Karina B, Tito Pedro A L, Silveira Josianne N, Pianetti Gerson A, Byrro Ricardo M D, Peles Patrícia R H, Pereira Fernando H, Santos Thiago R, Assini Arthur G, Ribeiro Valéria V, Moraes Edgar N, Caramelli Pau |
|
Effect of the CYP2D6 and APOE Polymorphisms on the Efficacy of Donepezil in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis.
CNS drugs 2016 Jun . Xiao Tingting, Jiao Bin, Zhang Weiwei, Tang Beisha, Shen |
|
Donepezil plasma concentrations, CYP2D6 and CYP3A4 phenotypes, and cognitive outcome in Alzheimer's disease.
European journal of clinical pharmacology 2016 Mar . Coin A, Pamio M V, Alexopoulos C, Granziera S, Groppa F, de Rosa G, Girardi A, Sergi G, Manzato E, Padrini |
|
The roles of apolipoprotein E3 and CYP2D6 (rs1065852) gene polymorphisms in the predictability of responses to individualized therapy with donepezil in Han Chinese patients with Alzheimer's disease.
Neuroscience letters 2016 Feb 614 43-8. Lu Jin, Fu Jianliang, Zhong Yuan, Chen Pengguo, Yang Quanjun, Zhao Yuwu, Wan Lili, Guo Che |
|
Stereoselective metabolism of donepezil and steady-state plasma concentrations of S-donepezil based on CYP2D6 polymorphisms in the therapeutic responses of Han Chinese patients with Alzheimer's disease.
Journal of pharmacological sciences 2015 Nov . Lu Jin, Wan Lili, Zhong Yuan, Yu Qi, Han Yonglong, Chen Pengguo, Wang Beiyun, Li Wei, Miao Ya, Guo Che |
|
Evaluation of Candidate Genes Related to Neuronal Apoptosis in Late-Onset Alzheimer’s Disease.
Journal of Alzheimer's disease : JAD 2015 45 (2): 621-9. Moreno-Grau Sonia, Barneda Bruna, Carriba Paulina, Marín Juan, Sotolongo-Grau Oscar, Hernández Isabel, Rosende-Roca Maitée, Mauleón Ana, Vargas Liliana, Espinosa Ana, Alegret Montserrat, Rodriguez Octavio, Ortega Gemma, Fernández Maria Victoria, López-Arrieta Jesús, Tárraga Lluís, Boada Mercè, Antúnez Carmen, López Joaquin, Ruiz Agustín, Comella Joan Xavi |
|
Predictive factors of clinical response to cholinesterase inhibitors in mild and moderate Alzheimer's disease and mixed dementia: a one-year naturalistic study.
Journal of Alzheimer's disease : JAD 2015 45 (2): 609-20. Miranda Luís F J R, Gomes Karina B, Silveira Josianne N, Pianetti Gerson A, Byrro Ricardo M D, Peles Patrícia R H, Pereira Fernando H, Santos Thiago R, Assini Arthur G, Ribeiro Valéria V, Tito Pedro A L, Matoso Rafael O, Lima Thiago O L, Moraes Edgar N, Caramelli Pau |
|
Quantitative assessment of CYP2D6 polymorphisms and risk of Alzheimer's disease: a meta-analysis.
Journal of the neurological sciences 2014 Aug 343 (1-2): 15-22. Lu Yu, Qin Xue, Li Shan, Zhang Xiaolian, He Yu, Peng Qiliu, Deng Yan, Wang Jian, Xie Li, Li Taijie, Zeng Zhi |
|
Association between inherited CYP2D6/2C19 phenotypes and anticholinergic measures in elderly patients using anticholinergic drugs.
Therapeutic drug monitoring 2014 Feb 36 (1): 125-30. Kersten Hege, Wyller Torgeir B, Molden Esp |
|
Polymorphism in Cytochrome P450 2D6, Glutathione S-Transferases Pi 1 Genes, and Organochlorine Pesticides in Alzheimer Disease: A Case-Control Study in North Indian Population.
Journal of geriatric psychiatry and neurology 2014 Feb 27 (2): 119-127. Singh Neeraj Kumar, Banerjee B D, Bala Kiran, Basu Mitra, Chhillar Neel |
|
Impact of CYP2D6 and CYP3A4 genetic polymorphism on combined cholinesterase inhibitors and memantine treatment in mild to moderate Alzheimer's disease.
Dementia and geriatric cognitive disorders 2014 37 (1-2): 58-70. Sonali Nirmal, Tripathi Manjari, Sagar Rajesh, Velpandian Thirumurthy, Subbiah Vivekanandh |
|
Relationship of CYP2D6, CYP3A, POR, and ABCB1 genotypes with galantamine plasma concentrations.
Therapeutic drug monitoring 2013 Apr 35 (2): 270-5. Noetzli Muriel, Guidi Monia, Ebbing Karsten, Eyer Stephan, Zumbach Serge, Giannakopoulos Panteleimon, von Gunten Armin, Csajka Chantal, Eap Chin |
|
Effect of CYP2D6*10 and APOE polymorphisms on the efficacy of donepezil in patients with Alzheimer's disease.
The American journal of the medical sciences 2013 Mar 345 (3): 222-6. Zhong Yuan, Zheng Xueli, Miao Ya, Wan Lili, Yan Hong, Wang Beiy |
|
Clinical Effectiveness of Rivastigmine Monotherapy and Combination Therapy in Alzheimer's Patients.
CNS neuroscience & therapeutics 2012 Dec . Sonali N, Tripathi M, Sagar R, Velpandian T, Subbiah V |
|
Replication study to confirm the role of CYP2D6 polymorphism rs1080985 on donepezil efficacy in Alzheimer's disease patients.
Journal of Alzheimer's disease : JAD 2012 30 (4): 745-9. Albani Diego, Martinelli Boneschi Filippo, Biella Gloria, Giacalone Giacomo, Lupoli Sara, Clerici Francesca, Benussi Luisa, Ghidoni Roberta, Galimberti Daniela, Squitti Rosanna, Mariani Stefania, Confaloni Annamaria, Bruno Giuseppe, Mariani Claudio, Scarpini Elio, Binetti Giuliano, Magnani Giuseppe, Franceschi Massimo, Forloni Gianlui |
|
BCHE and CYP2D6 genetic variation in Alzheimer's disease patients treated with cholinesterase inhibitors.
European journal of clinical pharmacology 2011 Nov 67 (11): 1147-57. Chianella Caterina, Gragnaniello Daniela, Maisano Delser Pierpaolo, Visentini Maria Francesca, Sette Elisabetta, Tola Maria Rosaria, Barbujani Guido, Fuselli Silv |
|
Role of cytochrome P4502D6 functional polymorphisms in the efficacy of donepezil in patients with Alzheimer's disease.
Pharmacogenetics and genomics 2011 Apr 21 (4): 225-30. Seripa Davide, Bizzarro Alessandra, Pilotto Andrea, D'onofrio Grazia, Vecchione Gennaro, Gallo Antonietta P, Cascavilla Leandro, Paris Francesco, Grandone Elvira, Mecocci Patrizia, Santini Stefano A, Masullo Carlo, Pilotto Alber |
|
Effectiveness of a high-throughput genetic analysis in the identification of responders/non-responders to CYP2D6-metabolized drugs.
Clinical laboratory 2011 57 (11-12): 887-93. Savino Maria, Seripa Davide, Gallo Antonietta P, Garrubba Maria, D'Onofrio Grazia, Bizzarro Alessandra, Paroni Giulia, Paris Francesco, Mecocci Patrizia, Masullo Carlo, Pilotto Alberto, Santini Stefano |
|
Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease.
Neurology 2009 Sep 73 (10): 761-7. Pilotto Alberto, Franceschi M, D'Onofrio G, Bizzarro A, Mangialasche F, Cascavilla L, Paris F, Matera M G, Pilotto Andrea, Daniele A, Mecocci P, Masullo C, Dallapiccola B, Seripa |
|
Genetic analysis of Alzheimer's disease in the Uppsala Longitudinal Study of Adult Men.
Dementia and geriatric cognitive disorders 2009 27 (1): 59-68. Giedraitis Vilmantas, Kilander Lena, Degerman-Gunnarsson Malin, Sundelöf Johan, Axelsson Tomas, Syvänen Ann-Christine, Lannfelt Lars, Glaser An |
|
Polymorphisms of catechol-0-methyltransferase (COMT), monoamine oxidase B (MAOB), N-acetyltransferase 2 (NAT2) and cytochrome P450 2D6 (CYP2D6) gene in patients with early onset of Parkinson's disease.
Parkinsonism & related disorders 2007 May 13 (4): 224-9. Bialecka M, Klodowska-Duda G, Honczarenko K, Gawro?ska-Szklarz B, Opala G, Safranow K, Dro?dzik |
|
Impact of the CYP2D6 polymorphism on steady-state plasma concentrations and clinical outcome of donepezil in Alzheimer's disease patients.
European journal of clinical pharmacology 2006 Sep 62 (9): 721-6. Varsaldi Federica, Miglio Gianluca, Scordo Maria Gabriella, Dahl Marja-Liisa, Villa Laura Maria, Biolcati Aldo, Lombardi Graz |
|
No association between CYP2D6 polymorphism and Alzheimer's disease in an Italian population.
Pharmacological research 2006 Feb 53 (2): 162-5. Scordo Maria Gabriella, Dahl Marja-Liisa, Spina Edoardo, Cordici Francesco, Arena Maria Graz |
|
Septin 3 gene polymorphism in Alzheimer's disease.
Gene expression 2004 11 (5-6): 263-70. Takehashi Masanori, Alioto Tyler, Stedeford Todd, Persad Amanda S, Banasik Marek, Masliah Eliezer, Tanaka Seigo, Ueda Kunihi |
|
Effects of smoking and cytochrome P450 2D6*10 allele on the plasma haloperidol concentration/dose ratio.
Progress in neuro-psychopharmacology & biological psychiatry 2003 Sep 27 (6): 945-9. Ohara Koichi, Tanabu Shigeru, Yoshida Kimiko, Ishibashi Kazuhisa, Ikemoto Keiko, Shibuya Har |
|
Debrisoquine hydroxylase gene polymorphism (CYP2D6*4) in dementia with Lewy bodies.
Journal of neurology, neurosurgery, and psychiatry 2003 Jan 74 (1): 135-6. Huckvale C, Richardson A M T, Mann D M A, Pickering-Brown S |
|
CYP2D6*4 polymorphism is not associated with Parkinson's disease and has no protective role against Alzheimer's disease in the Korean population.
Psychiatry and clinical neurosciences 2001 Aug 55 (4): 373-7. Woo S I, Kim J W, Seo H G, Park C H, Han S H, Kim S H, Kim K W, Jhoo J H, Woo J |
|
No evidence of an association between CYP2D6 polymorphisms among Japanese and dementia with Lewy bodies.
Psychiatry and clinical neurosciences 2001 Apr 55 (2): 89-92. Furuno T, Kawanishi C, Iseki E, Onishi H, Sugiyama N, Suzuki K, Kosaka |
|
[Is it personalized treatment of dementia based on the CYP2D6 gene polymorphism possible?]
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 0 118 (6. Vyp. 2): 90-94. Chebotareva A D, Levin O S, Markov D D, Sychev D A, Grishina E |
|
CYP2D6 gene polymorphism as a probable risk factor for Alzheimer's disease and Parkinson's disease with dementia.
Neurologia i neurochirurgia polska 0 41 (2): 113-21. Go?ab-Janowska Monika, Honczarenko Krystyna, Gawro?ska-Szklarz Barbara, Potemkowski Andrz |
- Page last reviewed:Mar 16, 2019
- Page last updated:Sep 18, 2020
- Content source: